导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.17% | 557/1050 |
| 近一周 | -2.36% | 565/1104 |
| 近一月 | -4.05% | 499/1102 |
| 近一季 | -8.95% | 620/1092 |
| 近半年 | -2.90% | 513/1070 |
| 近一年 | 8.30% | 382/1018 |
| 近两年 | 55.48% | 462/926 |
| 近三年 | 27.21% | 412/834 |
| 成立以来 | 172.95% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.29% 734/1070 |
15.37% 443/1101 |
- - |
- - |
| 2025 | 29.43% 480/1065 |
4.19% 464/1014 |
-1.13% 784/1038 |
24.41% 457/1050 |
1.00% 400/1065 |
| 2024 | 6.04% 393/1011 |
-4.65% 554/960 |
-1.99% 440/983 |
15.87% 184/991 |
-2.07% 455/1011 |
| 2023 | -20.37% 678/952 |
-1.94% 708/880 |
-10.54% 785/895 |
-4.56% 270/915 |
-4.89% 486/952 |
| 2022 | -19.68% 316/867 |
-20.86% 566/773 |
12.28% 182/806 |
-16.07% 620/845 |
7.71% 119/867 |
| 2021 | 6.23% 286/740 |
-5.41% 356/580 |
17.99% 188/659 |
-9.22% 487/704 |
4.84% 236/740 |
| 2020 | 97.78% 37/554 |
-3.41% 243/419 |
34.31% 76/466 |
24.07% 22/517 |
22.87% 91/554 |
| 2019 | 49.57% 152/410 |
26.58% 582/1149 |
0.39% 291/1231 |
6.35% 174/390 |
10.66% 145/410 |
| 2018 | -22.92% 114/349 |
- - |
- - |
- - |
-10.56% 335/1080 |
| 2017 | 9.44% 135/285 |
- - |
- - |
- - |
- - |
| 2016 | 12.41% 5/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 泓德战略转型股票 VS. 东吴新产业精选股票A(580008) |